3 Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancerSarah P. Blagden, Hani Gabra, D. Smith et al.|European Journal of Cancer|2014Cited by 8